EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Affi-BAMS™: A Robust Targeted Proteomics Microarray Platform to Measure Histone Post-Translational Modifications

Ghaith M Hamza iD, Eric Miele, Don M Wojchowski, Paul Toran, Camilla R Worsfold, Tamil S Anthonymuthu, Vladislav B Bergo, Andrew X Zhang, Jeffrey C Silva

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241210060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ghaith M Hamza und 8 weiteren Autor:innen. Beteiligte Einrichtung: Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Boston, MA 02451, USA. Hauptthemen laut MEDLINE: Histones, Proteomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, UNH’s CoRE seed grant program (DMW, PI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For targeted protein panels, the ability to specifically assay post-translational modifications (PTMs) in a quantitative, sensitive, and straightforward manner would substantially advance biological and pharmacological studies. The present study highlights the effectiveness of the Affi-BAMS™ epitope-directed affinity bead capture/MALDI MS platform for quantitatively defining complex PTM marks of H3 and H4 histones. Using H3 and H4 histone peptides and isotopically labelled derivatives, this affinity bead and MALDI MS platform achieves a range of >3 orders of magnitude with a technical precision CV of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesProteomicsTandem Mass SpectrometryProtein Processing, Post-TranslationalHistone CodePeptidesAcetylation

Stichwörter der Autor:innen

BAMSMALDI MSPTMshistonesimmunoaffinity peptide captureproteomics

Substanzen

HistonesPeptides

Autor:innen und Institutionen

  • Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Boston, MA 02451, USA.
  • Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH 03824, USA.
  • Adeptrix Corporation, Beverly, MA 01915, USA.
  • Cell Signaling Technology, Danvers, MA 01915, USA.

ORCID-Profile: Ghaith M Hamza

Förderung

  • NCI NIH HHS
  • UNH’s CoRE seed grant program (DMW, PI)

Zitieren

APA

Hamza, G. M., Miele, E., Wojchowski, D. M., Toran, P., Worsfold, C. R., Anthonymuthu, T. S., Bergo, V. B., Zhang, A. X., & Silva, J. C. (2023). Affi-BAMS™: A Robust Targeted Proteomics Microarray Platform to Measure Histone Post-Translational Modifications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241210060

Vancouver

Hamza GM, Miele E, Wojchowski DM, Toran P, Worsfold CR, Anthonymuthu TS, et al. Affi-BAMS™: A Robust Targeted Proteomics Microarray Platform to Measure Histone Post-Translational Modifications. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241210060

BibTeX
@article{Hamza2023,
  author = {Hamza, Ghaith M and Miele, Eric and Wojchowski, Don M and Toran, Paul and Worsfold, Camilla R and Anthonymuthu, Tamil S and Bergo, Vladislav B and Zhang, Andrew X and Silva, Jeffrey C},
  title = {Affi-BAMS™: A Robust Targeted Proteomics Microarray Platform to Measure Histone Post-Translational Modifications},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241210060}
}
Kostenlos starten →